KN-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KN-002, covering 2024-08-07 to 2024-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Single and Multiple Ascending Dose Study of KN-002 [Phase 1]